Reading and writing the code of life

At Horizon Holdings, we develop novel CRISPR systems that open up new avenues for biological expansion. We are addressing challenges in healthcare, agriculture, environmental monitoring, and biodefense with our revolutionary method for molecular diagnostics.

Horizon Holdings is cognizant of the fact that up to 40% of American adults struggle with mental health or substance abuse disorders. Psychedelics may hold the key to resolving the global crisis of mental health and well-being. Horizon Holdings' psychedelic Sector Insights is the definitive source for analysis of the rapidly growing psychedelic medicine industry. Distinguish yourself from the crowd with exclusive news, interviews, data, and investment opportunities in psychedelics.

We discover and develop genes with beneficial effects on plants more effectively than ever before using our novel technology. We emphasize beneficial effects such as increased yield, drought resistance, herbicide and insect tolerance.

Case in Point

Our genes are being integrated into the world's largest crops (Cannabis, Hemp, Soy, Corn, and Canola, to name a few) through genetic modification and gene editing processes. Patents- We filed patents on our novel technology and all genes discovered as a result of it.

Partners in Strategy

We collaborate with international seed companies.

We are pioneers in the development of external applications based on RNAi for crop protection and yield enhancement. Externally applied RNAi molecules have a specific effect on specific genes for a defined time period, resulting in the desired beneficial effects. Patents - For each RNAi-based application that we develop, we obtain patent protection.

Case in Point

The first two projects are in advanced development stages and involve the use of RNAi to increase yield in Cannabis as well as the use of RNAi to control a global insect that attacks Cannabis, Hemp, and other agricultural species.

Partners in Strategy

We develop our products in collaboration with three strategic partners who are responsible for their production and commercialization.

We co-founded Targene with Seach Medical Group with the goal of revolutionizing the cannabis industry through gene-based innovations.

Case in Point

We are concentrating our efforts on three activities: (1) large-scale production of active molecules (such as CBD/THC) in a bioreactor, and (2) gene editing in Cannabis to create improved strains.

Our undergraduate degree programs include a Bachelor of Science, a Master of Science, and a Doctor of Philosophy in BioScience: Biodiversity, Ecology, and Evolution (BEE), Biomedical Science, Biochemistry and Molecular Biology, Life Science Education, and a Histotechnican Certificate that can be completed concurrently with one of our other programs. Whether you are interested in natural history, academic research, biotechnology, healthcare and medical professions, or education, you will discover an exciting array of degree options with a variety of flexible online course delivery options to suit your needs.

We offer a range of performance products backed by our rigorous research and development that are designed to provide superior nutrition for optimal growth and ROI. Powered by Horizon Holdings' advanced crop nutrition technologies, these performance fertilizers ensure not only the correct nutrient balance, but also the proper material consistency, providing growers with an efficient application experience and optimal nutrient distribution for increased yields.